Fe(CO)5 iron pentacarbonyl

Product name: Fe (CO) 5 iron pentacarbonyl
Product Description: Fe (CO) 5, the compounds of Co and Fe, the equation for the chemical reaction: 5CO + Fe → Fe (CO) 5
Physical properties: Under normal atmospheric, it was amber liquid, the density is 1.453 g / cm3 (20.0 ℃). Fe (CO) 5, the melting point is about -20.3 ℃, the point 103.6 ℃, the critical temperature of 286 ℃ boiling. The low temperature to the critical temperature, with the rise in temperature, it is easy to break Fe and Co.
Chemical properties:
1, Fe (CO) 5 is completely dissolved in benzine, benzene, tetrahydronaphthalene, benzaldehyde, acetone, bromination of benzene, benzene and the other solution dichloride.
2, of-15 ℃, steam carbonyl content mixed with the combustion air necessarily create; Less than 34 ℃ temperature, it may be a spontaneous combustion in air.
3, Fe (CO) 5 is very agile and easy to hydrogenated carbonyl content H2Fe (CO) 4 and a metal salt Na2Fe (CO) 4, Fe content halogenating carbonyl (CO) 4I2, and Gerber acyl Fe carbonyl content (CO) 2 form (NO) 2, carbonyl fullerenes [C5H5Fe (CO) 2] and other compounds.
4, Fe (CO) 5 photochemical performance is lively, under the light, Fe (CO) 5 is easy to resolve.
5 depending on the critical temperature of Fe (CO) 5, under normal atmospheric pressure and more than 286 ℃ for thermal decomposition is the most important application of Fe (CO) 5, and is the easiest way industrialization carbonyl .
Application: Pyrolysis micro powder / nano level carbonyl iron, nano iron oxide powder is, magnetic film at the nanometer scale, fiber, nine carbonyl two iron, gasoline, flame retardants, catalysts of anti-explosion agent, CEO of surface film coating, lithography mask iron, antibiotics etc.
Notes: Fe (CO) 5 is tasteless, toxic, flammable, explosive brown liquid, in transportation and storage, we should pay attention to:
1.iron pentacarbonyl be provided in anaerobic jars under sealed metal pressure in air.
2. iron pentacarbonyl should be stored in a cool, well-ventilated place, avoid direct sunlight, away from fire, heat source.
3. gentle with her collision prohibited.

LIN28A Antibody (N-term)

Product Name: LIN28A Antibody (N-term)

Other Names: Lin-28 homolog A; Zinc finger CCHC domain-containing protein 1; LIN28; CSDD1; LIN28A; ZCCHC1.

Target/Specificity: This LIN28A rabbit antibody immunized with a KLH conjugate produced synthetic peptide is between 17 ~ 47 amino acids of the N-terminal region of human LIN28A.

Application Notes: 
The suggested dilution is: 
ELISA        1:1,000 
Western blotting      1:100~500 
Immunohistochemistry        1:10~50   
   
Format:supplied to the in PBS purified polyclonal antibody containing 0.09% (w / v) sodium azide. This antibody was purified by protein A column followed by purification by affinity peptide.

Storage: Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Precautions: LIN28A Antibody (N-term) is for re

For more, please click:http://www.6cbiotech.com/Stem-Cell/

Betamethasone

A glucocorticoid orally, parenterally, applied by local injection, inhalation, or topically in the treatment of various diseases, including corticosteroids are called. His lack of mineralocorticoid is betamethasone particularly suitable for cerebral edema and congenital adrenal hyperplasia Treaty.

Erythropoietin for sale

haracters：
white powder
Application range：
widely applied in pharmaceutical, food, health care and other industries.
Use：
Erythropoietin, also known as erythropoetin or erthropoyetin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.

Tylosin hydrogen tartrate

Product name: Tylosin hydrogen tartrate
CAS:74610-55-2 
Molecular Formula: 2(C46H77NO17)·C4H6O6
Molecular Weight:1982.31 
Product description:Have effects on mycoplasma, used as a drug of choice for mycoplasma disease resistance.

Alexion faced with a choice of new drugs for rare diseases!

Development of drugs for rare diseases is extremely small patient population. This also resulted in extremely high price of rare disease therapies. How to measure the cost-effective therapy for rare diseases is high or low is placed in front of the world pharmaceutical administration is an important issue, and orphan drug prices with pharmaceutical companies is the focus of the Governing Body Game. Recently, the British NICE price management department in considering whether to grant Alexion developed orphan drug for the treatment of infants Kanuma lysosomal acid lipase deficiency (LAL deficiency). However, NICE managers think we need more data to make definitive conclusions.

Previously published a draft NICE believes the therapy of up to 491,992 pounds ($ 704,630) price is too high, is not suitable to be generalized to all patients. However, Alexion is still plenty of time to persuade NICE to change his mind. Lack of lysosomal acid lipase disease more common in patients with a baby due to lack of lysosomal acid lipase, patient cells will accumulate excess fatty acids. Survival of sick babies often less than 12 months.

Alexion said, unfortunately NICE failed to see the seriousness of this disease. However, the company's requirements for how to deal with NICE also have experienced. December 2014, the company finally persuaded NICE approval of another rare disease treatment with atypical hemolytic-uremic syndrome drug Soliris for launch in the UK market. In this case, Alexion's Soliris company did not provide data to the R & D funding NICE. However, a year later, another drug company Strensiq not so good luck. Such a medicament for the treatment of rare hypophosphatasia each course cost more than $ 500,000, eventually NICE labeled low price tag and turned away. Today, Alexion carry Kanuma knock the door once again the British market, but also come up with their sincerity.

Bryostatin 1

A macrocyclic lactone bryozoan Bugula Neritina with isolated antineoplastic activity. Bryostatin 1 binds to and inhibits the enzyme, protein kinase C, cell signaling, which in the inhibition of tumor cell proliferation, promoting the differentiation of tumor cells and the induction of apoptosis tumor cells the agent can act synergistically with other chemotherapeutic agents.